Merriman Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$419K Sell
15,779
-171
-1% -$4.54K 0.02% 146
2024
Q3
$462K Buy
15,950
+94
+0.6% +$2.72K 0.02% 149
2024
Q2
$444K Sell
15,856
-233
-1% -$6.52K 0.02% 144
2024
Q1
$446K Buy
16,089
+1,506
+10% +$41.8K 0.02% 140
2023
Q4
$420K Buy
14,583
+137
+0.9% +$3.94K 0.02% 138
2023
Q3
$479K Sell
14,446
-220
-2% -$7.3K 0.02% 120
2023
Q2
$538K Buy
14,666
+71
+0.5% +$2.6K 0.03% 131
2023
Q1
$595K Buy
14,595
+185
+1% +$7.55K 0.03% 119
2022
Q4
$738K Sell
14,410
-874
-6% -$44.8K 0.04% 122
2022
Q3
$669K Sell
15,284
-715
-4% -$31.3K 0.04% 85
2022
Q2
$839K Buy
15,999
+571
+4% +$29.9K 0.06% 73
2022
Q1
$799K Sell
15,428
-2,555
-14% -$132K 0.07% 94
2021
Q4
$1.06M Buy
17,983
+4,154
+30% +$245K 0.08% 100
2021
Q3
$595K Buy
13,829
+393
+3% +$16.9K 0.05% 126
2021
Q2
$526K Buy
13,436
+314
+2% +$12.3K 0.05% 159
2021
Q1
$475K Sell
13,122
-2,245
-15% -$81.3K 0.05% 135
2020
Q4
$566K Buy
15,367
+967
+7% +$35.6K 0.06% 138
2020
Q3
$501K Sell
14,400
-952
-6% -$33.1K 0.07% 106
2020
Q2
$476K Sell
15,352
-1,626
-10% -$50.4K 0.08% 108
2020
Q1
$526K Sell
16,978
-710
-4% -$22K 0.11% 83
2019
Q4
$658K Buy
17,688
+2,330
+15% +$86.7K 0.13% 115
2019
Q3
$524K Buy
15,358
+7,891
+106% +$269K 0.11% 114
2019
Q2
$3.1K Buy
7,467
+186
+3% +$77 0.06% 148
2019
Q1
$293K Sell
7,281
-417
-5% -$16.8K 0.06% 167
2018
Q4
$314K Sell
7,698
-2,018
-21% -$82.3K 0.07% 117
2018
Q3
$406K Sell
9,716
-3,877
-29% -$162K 0.09% 123
2018
Q2
$468K Buy
13,593
+487
+4% +$16.8K 0.11% 114
2018
Q1
$441K Buy
13,106
+1,375
+12% +$46.3K 0.12% 129
2017
Q4
$403K Buy
11,731
+2,327
+25% +$79.9K 0.1% 127
2017
Q3
$319K Buy
+9,404
New +$319K 0.08% 125